Market Place
Sourcing Support
Exo Therapeutics Announces Poster At ACR Convergence
22 Oct 2024 //
BUSINESSWIRE
Exo Therapeutics Presents TBK1/STING Inhibitor Data At FOCIS 2024
20 Jun 2024 //
BUSINESSWIRE
Exo Announces Lead Program, Targeting TANK Binding Kinase 1
23 May 2023 //
BUSINESSWIRE
Exo Therapeutics Appoints Nagesh Mahanthappa as Executive Chair
04 Jan 2023 //
BUSINESSWIRE
Exo Tx Appoints Stephanos Ioannidis as Exec VP and Catherine Scholz as Senior VP
17 May 2022 //
BUSINESSWIRE
Exo Appoints Dorothy Lou Bailey as Senior VP Corporate Development and Strategy
26 Oct 2021 //
BUSINESSWIRE
Exo Therapeutics Raises $78 Million Series B for Enzyme Inhibitors
09 Oct 2021 //
TRIALSITES
Novartis-backed Exo says `XO` to investors for $78M series B
05 Oct 2021 //
FIERCEBIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.